http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news&action=article&articleid=8590929&from=rss RNS Number : 6665DArk Therapeutics Group PLC18 May 2012   [TABLE NOT SHOWN]   [TABLE NOT SHOWN]   [TABLE NOT SHOWN]   This information is provided by RNSThe company news service from the London Stock Exchange  END  ... Fri, 18 May 2012 12:02:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news&action=article&articleid=8590927&from=rss RNS Number : 6662DArk Therapeutics Group PLC18 May 2012   18 May 2012   Ark Therapeutics Group plc   Directors' Share Dealing     Ark Therapeutics Group plc (LSE: AKT) ("the "Company") has received notification that on 17 May 2012 Peter Keen, Non-Executive... Fri, 18 May 2012 12:01:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news&action=article&articleid=8590920&from=rss RNS Number : 6659DArk Therapeutics Group PLC18 May 2012   Results of Annual General Meeting     London, UK, 18 May 2012:  At the Annual General Meeting of Ark Therapeutics Group plc (LSE: AKT) held yesterday all resolutions were passed.   A summary of the proxy voting... Fri, 18 May 2012 11:57:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news&action=article&articleid=8588890&from=rss RNS Number : 5193DArk Therapeutics Group PLC17 May 2012       Ark Therapeutics Group plc   Interim Management Statement   17 May 2012 - Ark Therapeutics Group plc ("Ark" or the "Company") today publishes its interim management statement for the period from 1 ... Thu, 17 May 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news&action=article&articleid=8587361&from=rss RNS Number : 4179DArk Therapeutics Group PLC16 May 2012   ARK THERAPEUTICS GROUP PLC     Completion of the dose ranging Phase I section of refractory angina clinical study Enrolment into Phase IIa stage expected to begin Q3 2012     London, UK, 16 May 2012... Wed, 16 May 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news&action=article&articleid=8574032&from=rss RNS Number : 5208CArk Therapeutics Group PLC02 May 2012   ARK THERAPEUTICS GROUP PLC     Substantial EU Framework Programme 7 Grant awarded for clinical development of Ark's pre-clinical product candidate EG013 in the treatment of fetal growth restriction   Ark... Wed, 02 May 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news&action=article&articleid=8566318&from=rss RNS Number : 9835BArk Therapeutics Group PLC25 April 2012   ARK THERAPEUTICS GROUP PLC   Ark's newest manufacturing suite receives GMP approval   London, UK - 25 April 2012: Ark Therapeutics Group plc ("Ark" or the "Company") is pleased to announce that following inspection... Wed, 25 Apr 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news&action=article&articleid=8558861&from=rss RNS Number : 5106BArk Therapeutics Group PLC17 April 2012   17 April 2012     Ark Therapeutics Group plc (the "Company")   Director Shareholding     On 17 April 2012, the Company's Remuneration Committee (which is comprised wholly of non-executive directors)... Tue, 17 Apr 2012 14:36:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news&action=article&articleid=8550932&from=rss RNS Number : 9682AArk Therapeutics Group PLC10 April 2012   ARK THERAPEUTICS GROUP PLC   New Board Appointment   David Venables appointed as Executive Director - Manufacturing Services   London - 10 April 2012, London, UK: Ark Therapeutics Group plc ("Ark" ... Tue, 10 Apr 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news&action=article&articleid=8545900&from=rss RNS Number : 6395AArk Therapeutics Group PLC02 April 2012   ARK THERAPEUTICS GROUP PLC   31 March 2012   Annual Information Update     Ark Therapeutics Group plc (the "Company") is pleased to provide an annual information update in accordance with the requirements... Mon, 02 Apr 2012 15:25:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news&action=article&articleid=8537075&from=rss RNS Number : 0070AArk Therapeutics Group PLC26 March 2012   26 March 2012   Ark Therapeutics Group PLC   Broker Change of Name   Ark Therapeutics Group plc (AKT.L) announces that its Broker, Collins Stewart Europe Limited, has changed its name to Canaccord Genuity ... Mon, 26 Mar 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news&action=article&articleid=8528528&from=rss RNS Number : 4561ZArk Therapeutics Group PLC15 March 2012   15 March 2012   Ark Therapeutics Group plc   Directors' Share Dealing     Ark Therapeutics Group plc (LSE: AKT) ("the "Company") has received notification that on 14 March 2012:   1.      ... Thu, 15 Mar 2012 16:09:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news&action=article&articleid=8525828&from=rss RNS Number : 2783ZArk Therapeutics Group PLC13 March 2012   Ark Therapeutics Group plc Board Changes     London - 13 March 2012 - Ark Therapeutics Group plc is pleased to confirm the announcement contained in its preliminary results that Charles Spicer has been appointed... Tue, 13 Mar 2012 16:16:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news&action=article&articleid=8523310&from=rss RNS Number : 1120ZArk Therapeutics Group PLC12 March 2012   Ark Therapeutics Group plc   Preliminary results for the year ended 31 December 2011   London, UK, 12 March 2012 - Ark Therapeutics Group plc today announces its unaudited preliminary results for the year ended... Mon, 12 Mar 2012 07:00:00 GMT http://www.iii.co.uk/investment/detail?code=cotn:AKT.L&display=news&action=article&articleid=8507390&from=rss RNS Number : 0264YArk Therapeutics Group PLC23 February 2012       [TABLE NOT SHOWN]   [TABLE NOT SHOWN]   [TABLE NOT SHOWN]   This information is provided by RNSThe company news service from the London Stock Exchange  END  ... Thu, 23 Feb 2012 16:29:00 GMT